Healthcare • Biotechnology
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if VALN is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
4 top institutions tracked
Sentiment: unknown
No recent insider trades detected.
Red flags: 0
20 filers reported a long position in VALN for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | $12M | 2.3M | Unchanged |
| Vivo Capital, LLC | $4M | 763.2K | New |
| GENERAL AMERICAN INVESTORS CO INC | $1.9M | 354.4K | Unchanged |
| MILLENNIUM MANAGEMENT LLC | $707.2K | 135.2K | New |
| WELLS FARGO & COMPANY/MN | $403.8K | 77.2K | -1% |
| MORGAN STANLEY | $294K | 56.2K | +19.8% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | $235.7K | 45.1K | +79.3% |
| CITADEL ADVISORS LLC | $106.1K | 20.3K | New |
| XTX Topco Ltd | $79.4K | 15.2K | New |
| VSM Wealth Advisory, LLC | $52.3K | 10K | Unchanged |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.